期刊文献+

非小细胞肺癌淋巴管生成的研究及意义 被引量:1

Study on Significance of Lymphangiogenesis in Non-Small Cell Lung Cancer
原文传递
导出
摘要 目的探讨非小细胞肺癌(Non-Small CellLung Cancer,NSCLC)肿瘤间质淋巴管生成与临床病理因素之间的关系。方法应用抗Podoplanin单克隆抗体(Elivision法)对68例NSCLC术后石蜡切片进行染色,观察肿瘤间质和癌旁组织淋巴管密度(Lymphatic vessel density,LVD)。结果①癌旁组织中淋巴管密度平均值为7.50±0.21(3.5~11.4),肿瘤组织间质中LVD为11.91±0.60(4.5~21.5),两组相比差异有统计学意义(P<0.05);②按有无淋巴结转移分组,68例NSCLC肿瘤组织间质中淋巴结阳性患者LVD平均值为15.73±0.74,淋巴结阴性患者LVD平均值为8.31±0.32,两组相比差异有统计学意义(P<0.05);以(高分化+中分化)和(低分化+未分化)进行分组,其LVD分别为9.42±0.54和15.46±0.87,两组相比差异有统计学意义(P<0.05);以Ⅰ、Ⅱ和Ⅲa期进行分组,其LVD分别为8.21±0.32,15.19±1.04和15.20±1.01,各组内差异有统计学意义(P<0.05)。结论非小细胞肺癌组织中淋巴管密度在分期较晚的肿瘤和有淋巴结转移的肿瘤中显著增高,从而有望为NSCLC抗淋巴管生成的研究提供理论依据。 Objective To explore the relationships between tumor stroma lymphangiogenesis in non-small cell lung cancer (NSCLC) and clinicopathologic factors. Methods Podoplanin was detected in 68 paraffin sections of NSCLC by immunohistochemistry(Elivision Methods). The Lymphatic vessel density(LVD) in the tumor stroma and adjacent tissues was observed. Results ①LVD in the adjacent tissues of NSCLC ( 7.50 ± 0.21 ) was significantly lower than that in the tumor stroma ( 11.91 ± 0.60) ,P 〈 0.05. ②LVD in the group with metastasis of lymph node was significantly higher than another group without it ( 15.73 ± 0.74 vs 8.31 ± 0.32), P 〈 0.05, there was significant difference between the well differentiated group and the poor differentiated group ( 9.42 ± 0. 54 vs 15.46 ± 0.87 ), P 〈 0.05, LVD in the I stage ( 8.21 ± 0.32 ) was significant lower than that in Ⅱ,Ⅲa stages(15.19 ± 1.04,15.20 ± 1.01 ) ,P 〈0.05. Conclusion Lymphangiogenesis is closely related to tumor stages and lymph node metastasis. This result provides a theoretical basis for the research of anti-lymaphangiogenesis.
出处 《中华全科医学》 2009年第11期1148-1149,F0003,共3页 Chinese Journal of General Practice
基金 安徽省教育厅自然科学研究资助项目(KJ2008B53ZC)
关键词 非小细胞肺癌 淋巴管生成 淋巴管密度 癌旁组织 Non-Small Cell Lung Cancer Lymphangiogenesis Lymphatic vessel density Adjacent tissues
  • 相关文献

参考文献12

  • 1Rivadeneira DE, Simmons RM, Christos P J, et al. Predictive factors associated with axillary lymph node metastasis in TIa and TIb breast carcinomas :analysis in more than 900 patients [ J ]. J Am Coll Surg, 2000,191 (1) :1-6. 被引量:1
  • 2Regnard JF, Santelmo N, Romdhani N, et al. Bronchioloalveolar lung carcinoma: results of surgical treatment and prognostic factors [ J ]. Chest, 1998, 114 ( 1 ) :45-50. 被引量:1
  • 3Fu XL,Zhu XZ, Shi DR, et al. Study of prognostic predictors for non- small cell lung cancer[J]. Lung Cancer, 1999,23(2) :143-152. 被引量:1
  • 4Cunnick GH ,Jiang WG, Gomez KF, et al. lymphangiogenesis quantification using quantitative PCR and breast cancer as a model [ J ]. Biochem Biophys Res Commuu,2001,288(4) :1043-1046. 被引量:1
  • 5Austrian Breast and Colorectal Cancer Study Group. Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer [J]. Ann Surg,2004,240(2) :306-312. 被引量:1
  • 6Beasley N J, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer[ J]. Cancer Res, 2002,62(5) : 1315-1320. 被引量:1
  • 7Hall FT,Freeman JL,Asa SL,et al. Intratumoral Lymphatics and Lymph Node Metastasis in Papillary Thyroid Carcinoma[ J]. Archives of Otolaryngology-Head & Neck Surgery,2003,129(7) :716-719. 被引量:1
  • 8Persaud K, Tille JC, Liu M, et al. Involvement of the VEGF receptor 3 in tubularmorphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C [ J ]. Cell Sci ,2004,117 ( 13 ) :2745-2756. 被引量:1
  • 9Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries : podoplanin as a specific maker for lymphatic endothelium [ J ]. Am J Pathol, 1999,154:385-394. 被引量:1
  • 10Marc GA, Bradley KM, Steven AS. Focus on lymphangiogenesis in tumor metastasis[ J]. Cancer cell ,2005,7 : 121-127. 被引量:1

二级参考文献21

  • 1Oliver G. Lymphatic vasculature development[J].Nat Rev Immunol,2004,4:35 被引量:1
  • 2Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors[J].Cancer (Phila),1999,86:2406 被引量:1
  • 3Kriehuber E, Breiteneder Geleff S, Groeger M, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages[J].J Exp Med,2001,194(6): 797 被引量:1
  • 4Ichikura T, Tomimatsu S,Ohkura E,et al. Prognostic significance of the expression of vascular endothelial growth factor(VEGF) and VEGF-C in gastric carcinama[J].J Surg Oncol,2001,78(2):132 被引量:1
  • 5Vleugel MM,Bos R, van der Groep P, et al. Lack of lymphangiogenesis during breast carcinogenesis[J].J Clin Pathol,2004,57(7):746 被引量:1
  • 6Petri Bono,Veli-Matti Wasenius.High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer[J].Clin Cancer Res,2004,10:7144 被引量:1
  • 7Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular and functional properties[J].J Cell Biol,2003,163: 209 被引量:1
  • 8Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis[J].Nat Rev Cancer,2002,2: 573 被引量:1
  • 9Ohta Y, Shridhar V, Bright RK, et al. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma mmours[J]. Br J Cancer, 1999, 81(1):54-61 被引量:1
  • 10Arinaga M, Noguchi T, Takeno S, et al. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma[J]. Cancer, 2003, 97(2):457-464 被引量:1

共引文献20

同被引文献9

  • 1Stetler-Stevenson WG, Kleiner DE Jr. Molecular biology of cancer:In- vasion and metastasis [ M ]//DeVita VT Jr, Hellman S, Rosenberg SA, et al. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott Williams & Wilkins,2001:123-136. 被引量:1
  • 2Juarez J, Bendall L, Bt'adstock K. Chemokine and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis [ J ]. Curr Pharm Des,2004,10 ( 11 ) : 1245-1259. 被引量:1
  • 3Taichman RS, Cooper C, Keller ET, et al. Use of the stromal cell-de- rived factor-l/CXCR4 pathway in prostate cancer metastasis to bone [ J]. Cancer Res.2002.62(6) : 1832-1837. 被引量:1
  • 4Murphy PM. Chemokines and the molecular basis of CanCer metastasis [ J]. N Engl J Med,2001,345 ( 11 ) :833-835. 被引量:1
  • 5Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4[ J]. Semin Cancer Biol,2004,14(3) :171-179. 被引量:1
  • 6Su L,Zhang J,Xu H,et al. Differential expression of CXCR4 is associ- ated with the metastatic potential of human non-small cell lung cancer ceils[ J]. Clin Cancer Res ,2005,11 ( 23 ) :8273-8280. 被引量:1
  • 7Lapteva N,Yang AG, Sanders DE, et al. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth iIlvivo[ J]. CancerGcne Ther,2005,12( 1 ) :84-89. 被引量:1
  • 8徐永,张素珍,黄培春,陈锦,蔡康荣.趋化因子受体CXCR4在鼻咽癌细胞中的表达[J].癌症,2004,23(2):136-140. 被引量:15
  • 9王杰,欧周罗,邵志敏.CXCL12-CXCR4生物学轴与肿瘤转移[J].国外医学(肿瘤学分册),2004,31(5):326-330. 被引量:12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部